Epitopea
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Salisbury House Station Rd, Cambridge, C...Website
www.epitopea.comRevenue
$21.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Epitopea
Based in Cambridge, United Kingdom, and founded in 2021, Epitopea is a medtech company with a focus on cancer treatment.Explore more
Epitopea Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Epitopea your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Epitopea
Epitopea, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Epitopea has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Epitopea recently announced quarterly report
Check out if Epitopea is spiking on competitors!
Product Launch: Get notified when Epitopea launches new products
Funding: Get notified immidiatlly once Epitopea has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Epitopea had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Epitopea
Find 3 more new buyers
Compare Similar Companies to Epitopea
Compare insights from companies similar to Epitopea, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Epitopea is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Epitopea is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Epitopea.
Epitopea financials insights
Gather financial insights about Epitopea, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$650K
2024
Other Financing Round
$31M
Epitopea Tech Stack
A closer look at the technologies used by Epitopea
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Partnership
Partnership, Research & Development, Intellectual Property, Legal Affairs, Medical Research, Pharmaceuticals
Funding
Funding
Lateral Move
Executive Move
Executive Moves, Lateral Move
New Hire
Executive Move
Executive Moves, New Hire
Epitopea News & Media
Epitopea Strengthens Scientific Advisory Board with Appointment of Leading Authority in Cancer, Lisa Butterfield
CAMBRIDGE, United Kingdom and MONTREAL, April 13, 2026 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies for hard-to-treat solid tumors, today announced the appointment of Lisa Butterfield to its Scientific Advisory Board (SAB). A highly respected leader in immuno-oncology, Dr. Butterfield brings extensive expertise in cancer vaccines, immune profiling, biomarker development and cellular therapies for soEpitopea Strengthens Scientific Advisory Board with Appointment of Four World Renowned Experts in Cancer Immunology and Immunotherapy
CAMBRIDGE, United Kingdom and MONTREAL, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, today announced the appointment of four world leading experts to its Scientific Advisory Board (SAB): Prof. Nahum Sonenberg, Dr. Nina Bhardwaj, Dr. Maggie Callahan, and Dr. Craig L. Slingluff, Jr. Together, they bring deep expertise in immuno-oncology, translational research, and vaccine development,Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic
CAMBRIDGE, United Kingdom and MONTREAL, July 10, 2025 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, today announced the formation of its dedicated clinical team and the expansion of its research team. These developments represent a significant milestone in the company’s ongoing progress in advancing its RNA-based immunotherapies, known as CryptiVax™, into clinical trials.Epitopea Announces Nature Cancer Paper on Novel Immunotherapy Targets in Melanoma and NSCLC
Further Validates Cryptigens™ as Actionable Targets for Cancer Immunotherapy Further Validates Cryptigens™ as Actionable Targets for Cancer Immunotherapy
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Epitopea
Sign Up For FreeTo access detailed company insights
Based in Cambridge, United Kingdom, and founded in 2021, Epitopea is a medtech company with a focus on cancer treatment.... Read More
